Clinical Trial Update: Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery [Phase 4]

View source ↗

Summary

This entry describes a Phase 4 clinical trial evaluating subconjunctival bevacizumab to prevent bleb failure after glaucoma filtration surgery. The trial status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Grewal Eye Institute | Conditions: Glaucoma | Phase 4 | Status: UNKNOWN